Showing results (21-30 of 198) with videos related to

Sort By:
Pageof 20
Seminars in Thrombosis and Hemostasis|January 1, 1997
Anticoagulation in patients with heparin-induced thrombocytopenia type IIJ Harenberg, G Huhle, L Piazolo, et al.
Thrombosis and Haemostasis|June 30, 1989
Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteersJ Harenberg, C Giese, C E Dempfle, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assayJ Harenberg, B Haaf, C E Dempfle, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Comparison of the pharmacodynamic and pharmacokinetic profiles of two low-molecular-mass heparins in ratsL Piazolo, J Harenberg, R Malsch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 1, 1996
Effects of low-molecular-weight dermatan sulfate on coagulation, fibrinolysis and tissue factor pathway inhibitor in healthy volunteersJ Harenberg, M Jeschek, M Acker, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effectsJ Harenberg, G Stehle, C E Dempfle, et al.
Thrombosis Research|October 1, 1992
Heparin Study in Internal Medicine (HESIM): design and preliminary resultsJ Harenberg, P Roebruck, G Stehle, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1997
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosisJ Harenberg, G Stehle, M Blauth, et al.
Thrombosis Research|October 9, 1999
Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitorG Huhle, C Abletshauser, N Mayer, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1994
Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparinsR Malsch, J Harenberg, M Guerrini, et al.
Pageof 20